Efforts to control 'nightmare' bacteria working

Feds say system would be more effective if more hospitals and doctors participated


Federal health officials say a network they set up last year to identify deadly "nightmare bacteria" is helping control these germs, according to an article on the NPR website.

But they also admit the system would be more effective if more hospitals and doctors participated.

The Centers for Disease Control and Prevention (CDC) identified more than 1,400 people who tested positive for these kinds of germs last year.

In January 2017, the CDC established a nationwide network of labs to make it easier to identify the killer bacteria. The CDC says that the first nine months of that effort were successful. 

Read the article.

 



April 10, 2018


Topic Area: Infection Control


Recent Posts

Waco Family Medicine Achieves Savings and Bold Design with Wood Selections

Case study: The healthcare facility incorporated over 25,000 square feet of wood and saved over $400,000.


Alleged Ransomware Administrator Extradited from South Korea

The Phobos ransomware has been used globally to target over 1,000 organizations, including healthcare.


Design Plans Unveiled for New Intermountain St. Vincent Regional Hospital

The new hospital will be a 14-floor, 737,000 square-foot facility in Billings, Montana.


Ground Broken on New Pediatric Health Campus in Dallas

The new campus will replace the existing Children’s Medical Center Dallas.


Pre-Construction Strategies for Successful Facilities Projects

Savvy decisions can help facilities meet long-term goals by creating consistency and eliminating waste.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.